Top Markets
Coin of the day
Entia Biosciences, Inc. Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGO
Peringkat dalam Saham #41967
Entia Biosciences, Inc. engages in the development, production, and... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
Harga Saham
$0.0002
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$6.73K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
100.00%
Negara
US
Perdagangan Entia Biosciences, Inc. (ERGO)

Kategori

Laba untuk Entia Biosciences, Inc. (ERGO)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Entia Biosciences, Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Entia Biosciences, Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing